Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow Quality Index
Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Quality Index of 0.50x as of September 2025. Operating cash flow of ₩11.28 Billion is below net income of ₩22.41 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Il Dong Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Il Dong Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2018)
Historical Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Il Dong Pharmaceutical Co Ltd (249420) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Il Dong Pharmaceutical Co Ltd (2016–2018)
Year-by-year earnings quality comparison for Il Dong Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Il Dong Pharmaceutical Co Ltd stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 5.24x | ₩66.65 Billion | ₩12.72 Billion | ▲ +41.0% |
| 2017 | 3.72x | ₩73.72 Billion | ₩19.84 Billion | ▲ +1.7% |
| 2016 | 3.66x | ₩45.98 Billion | ₩12.58 Billion | — |